Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
S286554-5mg | 5mg | In stock | $45.90 | |
S286554-10mg | 10mg | In stock | $75.90 | |
S286554-25mg | 25mg | In stock | $171.90 | |
S286554-50mg | 50mg | In stock | $260.90 | |
S286554-100mg | 100mg | In stock | $391.90 | |
S286554-250mg | 250mg | In stock | $882.90 | |
S286554-1g | 1g | In stock | $3,175.90 |
Selective CB1inverse agonist
Synonyms | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide hydrochloride | Q27279980 | HSDB 8013 | AR-360/40191185 | DTXSID20166495 | RIMONABANT HYDROCHLORIDE [MI] | rimonabant hydrochloride;5-(4-chlorophenyl)-1-(2,4-d |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Potent and selective cannabinoid CB1receptor antagonist (Ki= 1.98 nM). Also acts as an inverse agonist reversing adenylyl cyclase inhibition byWIN 55,212-2 (IC50= 48 nM). Displays no activity at CB2receptors. Reduces food intake and body weight in orally |
Storage Temp | Store at -20°C,Desiccated |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of CB 1 receptor;Antagonist of GPR55 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide;hydrochloride |
---|---|
INCHI | InChI=1S/C22H21Cl3N4O.ClH/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15;/h5-10,13H,2-4,11-12H2,1H3,(H,27,30);1H |
InChi Key | REOYOKXLUFHOBV-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl.Cl |
Isomeric SMILES | CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl.Cl |
WGK Germany | 3 |
PubChem CID | 104849 |
Molecular Weight | 500.25 |
PubChem CID | 104850 |
---|---|
DrugBank Ligand | DB06155 |
CAS Registry No. | 158681-13-1 |
ChEBI | CHEBI:116088 |
Wikipedia | Rimonabant |
ChEMBL Ligand | CHEMBL111 |
RCSB PDB Ligand | AY6 |
DrugCentral Ligand | 4150 |
GPCRdb Ligand | rimonabant |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
F2208389 | Certificate of Analysis | Feb 15, 2022 | S286554 |
F2208390 | Certificate of Analysis | Feb 15, 2022 | S286554 |
F2208391 | Certificate of Analysis | Feb 15, 2022 | S286554 |
F2208392 | Certificate of Analysis | Feb 15, 2022 | S286554 |
F2208393 | Certificate of Analysis | Feb 15, 2022 | S286554 |
F2208394 | Certificate of Analysis | Feb 15, 2022 | S286554 |
F2208395 | Certificate of Analysis | Feb 15, 2022 | S286554 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 50.02, Max Conc. mM: 100;DMSO (Slightly), Methanol (Slightly) |
---|
Pictogram(s) | GHS06, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H319:Causes serious eye irritation H301:Toxic if swallowed |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P337+P317:If eye irritation persists: Get medical help. |
WGK Germany | 3 |
RIDADR | UN28116.1/PGIII |